These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 15321411

  • 1. In vitro evidence of gender-related heparin resistance.
    Monte S, Lyons G.
    Int J Obstet Anesth; 2004 Apr; 13(2):91-4. PubMed ID: 15321411
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Does hemodilution by the crystalloid priming solution derange the efficacy of anticoagulation during cardiopulmonary bypass?
    Srivastava AR, Banerjee A, Misra BB, Minhas H, Virmani S.
    J Card Surg; 2008 Apr; 23(3):239-45. PubMed ID: 18435639
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Use of thromboelastography to assess the combined role of pregnancy and obesity on coagulation: a prospective study.
    Sharma S, Uprichard J, Moretti A, Boyce H, Szydlo R, Stocks G.
    Int J Obstet Anesth; 2013 Apr; 22(2):113-8. PubMed ID: 23465802
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the effects of unfractionated heparin and the low-molecular-weight heparins dalteparin and enoxaparin on spontaneous platelet aggregation and adenosine diphosphate activity in platelets during the third trimester of pregnancy.
    Ajayi AA, Pharmacols FB, Cooper J, Horn EH, Rubin PC.
    Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):539-45. PubMed ID: 18040530
    [Abstract] [Full Text] [Related]

  • 8. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M, Velik-Salchner C, Stalzer B, Margreiter J, Klingler A, Streif W, Fries D, Innerhofer P.
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [Abstract] [Full Text] [Related]

  • 9. Use of thromboelastography to guide thromboprophylaxis after caesarean section.
    Boyce H, Hume-Smith H, Ng J, Columb MO, Stocks GM.
    Int J Obstet Anesth; 2011 Jul; 20(3):213-8. PubMed ID: 21641791
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
    Abou-Nassar K, Kovacs MJ, Kahn SR, Wells P, Doucette S, Ramsay T, Clement AM, Khurana R, Mackinnon K, Blostein M, Solymoss S, Kingdom J, Sermer M, Rey E, Rodger M, TIPPS investigators.
    Thromb Haemost; 2007 Jul; 98(1):163-71. PubMed ID: 17598009
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. In vivo and in vitro evaluation of the heparin management test versus the activated coagulation time for monitoring anticoagulation level in aprotinin-treated patients during cardiac surgery.
    Kim YS, Murkin JM, Adams SJ.
    Heart Surg Forum; 2004 Jul; 7(6):E599-604. PubMed ID: 15769695
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
    Scheuch G, Brand P, Meyer T, Herpich C, Müllinger B, Brom J, Weidinger G, Kohlhäufl M, Häussinger K, Spannagl M, Schramm W, Siekmeier R.
    J Physiol Pharmacol; 2007 Nov; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of clot formation process by treatment with the low-molecular-weight heparin nadroparin in patients with carotid artery disease undergoing angioplasty and stenting. A thromboelastography study on whole blood.
    Konstantinidis K, Gerasimidis T, Verdy E, Elalamy I, Samama MM, Gerotziafas GT.
    Thromb Haemost; 2007 Jan; 97(1):109-18. PubMed ID: 17200777
    [Abstract] [Full Text] [Related]

  • 18. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
    Melo FR, Mourão PA.
    Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
    [Abstract] [Full Text] [Related]

  • 19. Thrombelastography versus AntiFactor Xa levels in the assessment of prophylactic-dose enoxaparin in critically ill patients.
    Van PY, Cho SD, Underwood SJ, Morris MS, Watters JM, Schreiber MA.
    J Trauma; 2009 Jun; 66(6):1509-15; discussion 1515-7. PubMed ID: 19509608
    [Abstract] [Full Text] [Related]

  • 20. Xa inhibition and coagulation activity--the influence of prolonged dalteparin treatment and gender in patients with acute coronary syndrome and healthy individuals.
    Oldgren J, Johnston N, Siegbahn A.
    Am Heart J; 2008 Mar; 155(3):493.e1-8. PubMed ID: 18294482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.